KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deferred Tax LiabilityNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Teladoc Health (TDOC) Total Current Liabilities (2016 - 2025)

Teladoc Health's Total Current Liabilities history spans 12 years, with the latest figure at $404.7 million for Q4 2025.

  • For Q4 2025, Total Current Liabilities fell 57.01% year-over-year to $404.7 million; the TTM value through Dec 2025 reached $404.7 million, down 57.01%, while the annual FY2025 figure was $404.7 million, 57.01% down from the prior year.
  • Total Current Liabilities for Q4 2025 was $404.7 million at Teladoc Health, roughly flat from $405.1 million in the prior quarter.
  • Across five years, Total Current Liabilities topped out at $952.4 million in Q1 2025 and bottomed at $260.4 million in Q1 2021.
  • The 5-year median for Total Current Liabilities is $400.8 million (2022), against an average of $480.2 million.
  • The largest annual shift saw Total Current Liabilities soared 167.96% in 2021 before it crashed 57.01% in 2025.
  • A 5-year view of Total Current Liabilities shows it stood at $331.0 million in 2021, then grew by 20.77% to $399.8 million in 2022, then grew by 5.21% to $420.6 million in 2023, then soared by 123.85% to $941.5 million in 2024, then plummeted by 57.01% to $404.7 million in 2025.
  • Per Business Quant, the three most recent readings for TDOC's Total Current Liabilities are $404.7 million (Q4 2025), $405.1 million (Q3 2025), and $401.8 million (Q2 2025).